BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31585777)

  • 1. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
    Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
    Urol Oncol; 2019 Sep; 37(9):573.e19-573.e29. PubMed ID: 31358384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition.
    Sanfrancesco J; McKenney JK; Leivo MZ; Gupta S; Elson P; Hansel DE
    Arch Pathol Lab Med; 2016 Jun; 140(6):543-51. PubMed ID: 27031776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant Histology.
    de Jong JJ; Narayan VM; Cronican AA; Gupta S; van Leenders GJLH; Boormans JL; Gibb EA; Konety BR
    Am J Clin Pathol; 2021 Oct; 156(5):895-905. PubMed ID: 34157072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
    Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.
    Mo Q; Nikolos F; Chen F; Tramel Z; Lee YC; Hayashi K; Xiao J; Shen J; Chan KS
    J Natl Cancer Inst; 2018 May; 110(5):448-459. PubMed ID: 29342309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
    Fatima N; Osunkoya AO
    Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
    Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
    J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous invasion from sarcomatoid urothelial carcinoma: clinical and dermatopathologic features.
    Bernardes Filho F; de Melo AS; Pires AR; Lupi O; das Neves DG; da Cruz MF; Kac BK
    An Bras Dermatol; 2016; 91(1):73-9. PubMed ID: 26982782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder.
    Bertz S; Stöhr R; Gaisa NT; Wullich B; Hartmann A; Agaimy A
    Histopathology; 2020 Dec; 77(6):949-962. PubMed ID: 32645760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urothelial Carcinoma: Divergent Differentiation and Morphologic Subtypes.
    Gandhi J; Chen JF; Al-Ahmadie H
    Surg Pathol Clin; 2022 Dec; 15(4):641-659. PubMed ID: 36344181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients.
    Shelekhova KV; Krykow KA; Mescherjakov IA; Mitin NP
    Int J Surg Pathol; 2019 Aug; 27(5):483-491. PubMed ID: 30854907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation.
    Cheng L; Zhang S; Alexander R; Maclennan GT; Hodges KB; Harrison BT; Lopez-Beltran A; Montironi R
    Am J Surg Pathol; 2011 May; 35(5):e34-46. PubMed ID: 21490442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yolk sac differentiation in urothelial carcinoma - A rare variant originating from aberrant differentiation of sarcomatoid components.
    Krishnamurthy K; Rosen S; Ye H; Sun Y
    Ann Diagn Pathol; 2022 Jun; 58():151923. PubMed ID: 35180608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Potential Prognostic Markers for Muscle-Invasive Bladder Urothelial Carcinoma by Weighted Gene Co-Expression Network Analysis.
    Feng Y; Jiang Y; Wen T; Meng F; Shu X
    Pathol Oncol Res; 2020 Apr; 26(2):1063-1072. PubMed ID: 31011911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.
    Tajima S; Suzuki T; Yamada Y; Morikawa T; Minagawa D; Homma Y; Fukayama M
    Med Mol Morphol; 2016 Sep; 49(3):182-7. PubMed ID: 25690253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
    Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
    Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.